Genus plc

As of December 31, 2025, Genus Plc carries a market capitalization of 2.32B, placing it among publicly traded companies globally. Its enterprise value stands at 2.62B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Genus Plc's next confirmed earnings release is scheduled for February 25, 2027.

As of December 31, 2025, Genus Plc has 66.61M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Genus Plc maintains a current ratio of 2.25, meaning it holds 2.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 6, 2026, Genus Plc's stock has declined approximately 19.94% over the past 52 weeks. The 50-day moving average sits at 27.27, while the 200-day moving average is 28.45.

As of December 31, 2025, Genus Plc holds 58.48M in cash and equivalents against 351.27M in total debt, resulting in a net debt position of 256.28M. Total book value stands at 679.10M, with working capital of 227.85M providing operational flexibility.